期刊文献+

骨关节炎药物治疗现状及作用机制 被引量:3

Drug Treatment Action on Osteoarthritis and Its Mechanism
下载PDF
导出
摘要 随着对骨关节炎发病机制的深入研究,使通过药物对骨关节炎进行干预,延缓或逆转疾病进程成为可能。本文综述了近年来国内外学者对骨关节炎药物治疗的研究成果,从而为骨关节炎患者寻求确实有效的药物治疗方案提供了新的思路。 With the further study about pathogenesis of osteoarthritis,it is possible to delay or reverse the disease process by intervening it with drug. This article reviews osteoarthritis drug therapy researches by domestic and abroad scholars in recent years, in order to provide new idea of the effective therapeutic method for patients with osteoarthfitis.
出处 《医学综述》 2009年第8期1199-1202,共4页 Medical Recapitulate
基金 湖北省医疗卫生科技计划项目(A08302-10)
关键词 骨关节炎 药物 作用机制 Osteoarthritis Drug Mechanism of drug
  • 相关文献

参考文献23

二级参考文献15

  • 1张乃峥,施全胜,张雪哲,沙力进,王永和,赵淑霞,芦世华,于桂兰,屈辉.膝骨关节炎的流行病学调查[J].中华内科杂志,1995,34(2):79-83. 被引量:359
  • 2[1]Gierse JK, Hauser SD, Creely DP, et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J, 1995,305: 479 ~ 484. 被引量:1
  • 3[2]Emery P,Zeidler H, Kvien TK, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis:randomized doubleblind comparison.Lancet, 1999,354: 2106 ~2111. 被引量:1
  • 4[3]Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis:a randomized controlled trial. JAMA, 1999,282: 1992 ~ 1928. 被引量:1
  • 5[5]Silverstein FE,Faich G,Goldstein JL, et al. Gastrointestinal toxiety with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long - term Arthritis Safety Study. JAMA, 2000,284: 1247 ~ 1255. 被引量:1
  • 6Altman RD. Criteria for classification of clinical osteoarthritis. JRheumatol, 1991, 18 (Suppl 27): 10-12. 被引量:1
  • 7Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis, 1957, 16: 494-502. 被引量:1
  • 8Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinicallyimportant patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheumatol, 1988, 1: 95-108. 被引量:1
  • 9Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care, 1992, 30: 473-483. 被引量:1
  • 10Huskinson EC, Berry H, Gishen P, et al. Effects of anti-inflammatory drugs on the progression of osteoarhtritis of the knee. JRheumatol, 1995, 22: 1941-1946. 被引量:1

共引文献286

同被引文献33

  • 1郑诚功.骨科生物力学的进展[J].中华创伤骨科杂志,2005,7(10):901-902. 被引量:13
  • 2邱贵兴.骨关节炎流行病学和病因学新进展[J].继续医学教育,2005,19(7):68-69. 被引量:177
  • 3王常海,李峰.针刀“动态平衡”理论在膝骨性关节炎中的探讨[J].中华中医药学刊,2007,25(1):73-75. 被引量:37
  • 4Jensen CH,Rofail S.Knee injury and obesity in patients undergoing total knee replacement:a retrospective study in 115 patients.J Orthop Sci,2009,4:5-7. 被引量:1
  • 5Hart DJ,Spector TD.The relationship of obesity,fat distribution and oateoarthritis in women in the general population:the Chingford Study.J Rheumatol,2008,20:331-335. 被引量:1
  • 6Jan D.Ostoporosis and esteoarthritis.Anthropometric Distinctions,2008,249:448-451. 被引量:1
  • 7Reginster YJ,Deroisy R,Paul l,et al.Glucosamine sulfate significantly reduces progression of knee OA over 3 years;a large randomized,placebo-controlled,double-blind prospectivetrial.Arthritis Rheum,2009,42(suppl 9):S400-S413. 被引量:1
  • 8Pelletier JP,Yaron M,Haraoui B,et al.Efficacy and safety of diacerein in osteoarthritis of the knee:a double-blind,placebocontrolled trial:he Diacerein Study Group.Arthritis Rheum,2008,43:2339-2348. 被引量:1
  • 9Ladner V,Roberts CR,Franklin BN,et al.Human IL-1 ra gene transfer into human synovial fibroblasts is chondroportective.J Immunol,2009,158:3492. 被引量:1
  • 10Roessler BJ,Allen ED,Wilson JM,et al.Adnoviral mediated gene transfer to rabbit symovium in vivo.J Clin Invest,2008,92:1085. 被引量:1

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部